Fibrin/Schwann cell matrix in poly-epsilon-caprolactone conduits enhances guided nerve regeneration

International Journal of Artificial Organs

Volumn 27, Issue 2, 2004, Pages 127-136

  Galla, Thomas Jörg ^a,b   Vedecnik, S V ^a   Halbgewachs, J ^a   Steinmann, S ^a   Friedrich, C ^a   Stark, G B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Department of Plastic Surgery   (Germany)

Author keywords

Fibrin; Leukemia inhibitory factor; Peripheral nerve regeneration; Poly epsilon caprolactone; Schwann cells

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CELLS; DISEASES; TISSUE REGENERATION;

CAPROLACTONE; CELL MATRIX; CELL SUSPENSION; FIBRIN; LEUKAEMIA INHIBITORY FACTORS; NERVE REGENERATION; NEUROTROPHIC FACTORS; PERIPHERAL NERVE REGENERATION; POLY-EPSILON-CAPROLACTONE; SCHWANN CELLS;

NEURONS;

FIBRIN; LEUKEMIA INHIBITORY FACTOR; NEUROTROPHIC FACTOR; POLYCAPROLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL SUSPENSION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FACIAL NERVE; FEMALE; HISTOPATHOLOGY; IMPLANTATION; INNERVATION; MORPHOMETRICS; NERVE INJURY; NERVE REGENERATION; NONHUMAN; RAT; SCHWANN CELL; TISSUE ENGINEERING;

EID: 1842503921     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700208     Document Type: Article

References (43)

1. Grant GA, Goodkin R, Kliot M. Evaluation and surgical management of peripheral nerve problems. Neurosurgery 1999; 44: 825-39.
2. Terzis JK, Sun DD, Thanos PK. Historical and basic science review: Past, present, and future of nerve repair. J Reconstr Microsurg 1997; 13: 215-25.
3. Longo FM, Hayman EG, Davis GE, et al. Neurite-promoting factors and extracellular matrix components accumulating in vivo within nerve regeneration chambers. Brain Res 1984; 309: 105-17.
4. Rodriguez FJ, Gomez N, Perego G, Navarro X. Highly permeable polylactide-caprolactone nerve guides enhance peripheral nerve regeneration through long gaps. Biomaterials 1999; 20: 1489-500.
5. Evans GR. Challenges to nerve regeneration. Semin Surg Oncol 2000; 19: 312-8.
6. Galla TJ, Vedecnik S, Halbgewachs J, et al. A novel preformed autologous nerve guidance channel stimulates peripheral nerve regeneration. Tissue Eng 2003; (submitted).
7. Aldini N, Perego G, Cella GD, et al. Effectiveness of a bioabsorbable conduit in the repair of peripheral nerves. Biomaterials 1996; 17: 959-62.
8. den Dunnen WF, Stokroos I, Blaauw EH, et al. Light-microscopic and electron-microscopic evaluation of short-term nerve regeneration using a biodegradable poly (DL-lactide-epsilon-caprolactone) nerve guide. J Biomed Mater Res 1996; 31: 105-15.
9. den Dunnen WF, van der Lei B, Schakenraad JM, et al. Poly (DL-lactide-epsilon-caprolactone) nerve guides perform better than autologous nerve grafts. Microsurgery 1996; 17: 348-57.
10. Meek MF, den Dunnen WF, Schakenraad JM, Robinson PH. Long-term evaluation of functional nerve recovery after reconstruction with a thin-walled biodegradable poly (DL-lactide-epsilon-caprolactone) nerve guide, using walking track analysis and electrostimulation tests. Microsurgery 1999; 19: 247-53.
11. Rao MS, Sun Y, Escary JL, et al. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 1993; 11: 1175-85.
12. Dowsing BJ, Morrison WA, Nicola NA, Starkey GP, Bucci T, Kilpatrick TJ. Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. J Neurochem 1999; 73: 96-104.
13. Angelov DN, Krebs C, Walther M, et al. Altered expression of immune-related antigens by neuronophages does not improve neuronal survival after severe lesion of the facial nerve in rats. Glia 1998; 24: 155-71.
14. Jergovic D, Stal P, Lidman D, Lindvall B, Hildebrand C. Changes in a rat facial muscle after facial nerve injury and repair. Muscle Nerve 2001; 24: 1202-12.
15. Guntinas-Lichius O, Angelov DN, Tomov TL, Dramiga J, Neiss WF, Wewetzer K. Transplantation of olfactory ensheathing cells stimulates the collateral sprouting from axotomized adult rat facial motoneurons. Exp Neurol 2001; 172: 70-80.
16. Guntinas-Lichius O, Wewetzer K, Tomov TL, et al. Transplantation of olfactory mucosa minimizes axonal branching and promotes the recovery of vibrissae motor performance after facial nerve repair in rats. J Neurosci 2002; 22: 7121-31.
17. Brockes JP, Fields KL, Raff MC. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 1979; 165: 105-18.
18. Wewetzer K, Heiniger C, Seilheimer B. An improved cell-ELISA for the differential screening of antibodies against cell surface molecules of viable adherent Schwann cells. J Immunol Methods 1996; 191: 171-8.
19. Porter S, Clark MB, Glaser L, Bunge RP. Schwann cells stimulated to proliferate in the absence of neurons retain full functional capability. J Neurosci 1986; 6: 3070-8.
20. Bach AD, Bannasch H, Galla TJ, Bittner KM, Stark GB. Fibrin glue as matrix for cultured autologous urothelial cells in urethral reconstruction. Tissue Eng 2001; 7: 45-53.
21. Horch RE, Bannasch H, Kopp J, Andree C, Stark GB. Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis. Cell Transplant 1998; 7: 309-17.
22. Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991; 3: 207-12.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
24. Klinge PM, Vafa MA, Brinker T, et al. Immunohistochemical characterization of axonal sprouting and reactive tissue changes after long-term implantation of a polymide sieve electrode to the transected adult rat sciatic nerve. Biomaterials 2001; 22: 2333-43.
25. SNmba K, Egger MD. The facial "mOtor" nerve of the rat: control of vibrissal movement and examination of motor and sensory components. J Comp Neurol 1986; 247: 144-58.
26. Heath CA, Rutkowski GE. The development of bioartificial nerve grafts for peripheral-nerve regeneration. Trends Biotechnol 1998; 16: 163-8.
27. Meek MF, den Dunnen WF, Robinson PH, Pennings AJ, Schakenraad JM. Evaluation of functional nerve recovery after reconstruction with a new biodegradable poly (DL-lactide-epsilon-caprolactone) nerve guide. Int J Artif Organs 1997; 20: 463-8.
28. den Dunnen WF, Meek MF, Grijpma DW, Robinson PH, Schakenraad JM. In vivo and in vitro degradation of poly [(50)/(50) ((85)/(15)(L)/(D))LA/epsilon-CL], and the implications for the use in nerve reconstruction. J Biomed Mater Res 2000; 51: 575-85.
29. den Dunnen WF, van der Lei B, Robinson PH, Holwerda A, Pennings AJ, Schakenraad JM. Biological performance of a degradable poly (lactic acid-epsilon-caprolactone) nerve guide: Influence of tube dimensions. J Biomed Mater Res 1995; 29: 757-66.
30. Meek MF, Coert JH. Clinical use of nerve conduits in peripheral-nerve repair: Review of the literature. J Reconstr Microsurg 2002; 18: 97-109.
31. Gulati AK. Evaluation of acellular and cellular nerve grafts in repair of rat peripheral nerve. J Neurosurg 1988; 68: 117-23.
32. Hadlock T, Elisseeff J, Langer R, Vacanti J, Cheney M. A tissue-engineered conduit for peripheral nerve repair. Arch Otolaryngol Head Neck Surg 1998; 124: 1081-6.
33. Domb AJ, Amselem S, Maniar M. Biodegradable polymers as drug carrier systems. In: Dumitriu S. Biocompatibility of polymers. New York: Marcel Dekker Inc., 1994: Pp. 399-433.
34. Ali SA, Doherty PJ, Williams DF. Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo. Biomaterials 1994; 15: 779-85.
35. Lundborg G. How long can a nerve gap be without prohibiting spontaneously recovery? In: Gorio G, Millesi H, Mingrino S. Posttraumatic peripheral nePve regeneration. New York: Raven Press, 1981: pp. 109-31.
36. Gibson KL, Daniloff JK, Strain GM. Comparison of sciatic nerve regeneration through silicone tubes and nerve allografts. Microsurgery 1989; 10: 126-9.
37. Lundborg G, Dahlin LB, Danielsen N, et al. Nerve regeneration in silicone chambers: Influence of gap length and of distal stump components. Exp Neurol 1982; 76: 361-75.
38. Cheema SS, Richards LJ, Murphy M, Bartlett PF. Leukaemia inhibitory factor rescues motoneurones from axotomy-induced cell death. Neuroreport 1994; 5: 989-92.
39. Kurek JB, Bennett TM, Bower JJ, Muldoon CM, Austin L. Leukaemia inhibitory factor (LIF) production in a mouse model of spinal trauma. Neurosci Lett 1998; 249: 1-4.
40. Donato R, Cheema S, Finkelstein D, Bartlett P, Morrison W. Role of leukaemia inhibitory factor (LIF) in rat peripheral nerve regeneration. Ann Acad Med Singapore 1995; 24: 94-100.
41. Tham S, Dowsing B, Finkelstein D, et al. Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res 1997; 47: 208-15.
42. Galla TJ, Huber AA, Humar M, et al. Transfection of Schwann cells with LIF and its impact on nerve regeneration. Cells Tissues Organs 1999;1 66: 6-7.
43. Galla TJ, Huber AA, Humar M, et al. Transfizierte Schwann-Zellen als Drug-Delivery-Systeme in der peripheren Nervenregeneration. Acta Chirg Austriaca 2000; 32: 10-1.